Accelerate Diagnostics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Accelerate Diagnostics is offering 4,500,000 units and pre-funded units, each including common stock or pre-funded warrants and warrants, to raise capital for its Wave program and general corporate purposes.
Accelerate Diagnostics plans to offer 4,500,000 units, each with a share of common stock and a warrant, along with pre-funded units for certain investors.